Sort
21,453 grants matching “tuberculosis”
Biotin synthesis and biotin ligation in Mtb
$605,531Dirk Schnappinger · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · AI
Biotin synthesis and biotin ligation in Mtb
$605,531Dirk Schnappinger · Weill Medical Coll Of Cornell Univ · R01 · FY2014 · AI
Biotin synthesis and biotin ligation in Mtb
$605,531Dirk Schnappinger · Weill Medical Coll Of Cornell Univ · R01 · FY2012 · AI
HIV/AIDs and Orphan Care
$605,512Kathryn Whetten · Duke University · R01 · FY2010 · HD
Investigation of Indoor Solid Fuel and Kerosene Use as Tuberculosis Risk Factors
$605,413Michael N Bates · University Of California Berkeley · R01 · FY2012 · ES
PROCESS DEVELOPMENT OF TELACEBEC FOR TUBERCULOSIS
$605,287Desmond Slade · Midwest Research Institute · N01 · FY2024 · DA
ANALYSIS OF CHEMICAL STRUCTURES AND THERAPEUTIC ACTIVITY OF AGENTS FOR HIV AND TUBERCULOSIS (CHEMDB)
$605,222Rocco Casagrande · Gryphon Scientific, Llc · N01 · FY2018 · AI
Immunologic And Virologic Approaches To HIV-1 Therapeutics
$605,039Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
TUBERCULOSIS ELIMINATIONS AND LABORATORY GRANT APPLICATION
$605,020Lynn E Sosa · Connecticut State Dept Of Public Health · U52 · FY2012 · PS
The effect of inflammation and damage to lymph node structures on durable protective immunity following vaccination
$604,933Timothy W Schacker · University Of Minnesota · U01 · FY2020 · AI
Automated lung sound analysis to improve the clinical diagnosis of pulmonary tuberculosis in children
$604,832Devan Jaganath · University Of California, San Francisco · R01 · FY2024 · HL
Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. Tuberculosis
$604,694David M. Lewinsohn · Oregon Health & Science University · R01 · FY2020 · AI
Drug tourism to Mexico: Impact of Mexicos new drug law on HIV-HCV-TB in US IDUs
$604,516Richard S Garfein · University Of California, San Diego · R01 · FY2011 · DA
Hybrid trial for Alcohol reduction among people with TB and HIV in India (HATHI)
$604,510Amita Gupta · Johns Hopkins University · R01 · FY2021 · AA
TUBERCULOSIS ELIMINATION AND LABORATORY
$604,424Susan Jenkins · Missouri State Dept Of Social Services · U52 · FY2006 · PS
Lung-Protective Mechanisms of Metformin in TB
$604,331Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · HL
Passive-Active Immunization Strategies Against Pediatric AIDS
$604,079Marta L Marthas · University Of California At Davis · R01 · FY2007 · AI
Cell Migration in Tuberculosis Infection
$604,044Albert Einstein Col Of Med Yeshiva Univ · R01 · FY2005 · HL
Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment Monitoring
$604,028Anna M Mandalakas · Baylor College Of Medicine · R01 · FY2021 · AI
Longitudinal Analysis of Immune Signatures (IMS) of M. tuberculosis-specific T cells
$604,007Bjoern Peters · La Jolla Institute For Immunology · U19 · FY2022 · AI
CCR2 in Atherosclerosis and Monocyte Trafficking
$603,936Israel F. Charo · J. David Gladstone Institutes · R01 · FY2008 · HL
Human Subjects Core
$603,888Megan Murray · Brigham And Women'S Hospital · U19 · FY2016 · AI
Elucidating the mechanisms and consequences of MDSC-regulated immunity in TB
$603,802Joshua T. Mattila · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI
Regulation of T cell homeostasis and memory
$603,778Linda Mac Pherson Bradley · Univ Of Massachusetts Med Sch Worcester · P01 · FY2011 · AI
Improved understanding of TB transmission by accounting for within-host heterogeneity of M. tuberculosis: A population-based molecular epidemiology study in a high HIV prevalent setting
$603,738Sanghyuk Sam Shin · University Of California-Irvine · R01 · FY2024 · AI